GeoVax Labs, Inc. (GOVXW)

NASDAQ: GOVXW · Real-Time Price · USD · Warrants
0.0300
-0.0002 (-0.66%)
Apr 23, 2025, 10:00 AM EDT - Market open
-0.66%
Market Cap 11.32M
Revenue (ttm) 3.95M
Net Income (ttm) -24.99M
Shares Out 13.84M
EPS (ttm) -4.82
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,450
Open 0.0301
Previous Close 0.0302
Day's Range 0.0300 - 0.0301
52-Week Range 0.0331 - 0.0331
Beta 3.71
Analysts n/a
Price Target n/a
Earnings Date Mar 5, 2025

About GOVXW

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM0... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1988
Employees 17
Stock Exchange NASDAQ
Ticker Symbol GOVXW
Full Company Profile

Financial Performance

News

There is no news available yet.